M‐EA (methotrexate, etoposide, dactinomycin) and EMA‐CO (methotrexate, etoposide, dactinomycin / cyclophosphamide, vincristine) regimens as first‐line treatment of high‐risk gestational trophoblastic neoplasia

Singh, Kam ; Gillett, Sarah ; Ireson, Jane ; Hills, Anne ; Tidy, John A. ; Coleman, Robert E. ; Hancock, Barry W. ; Winter, Matthew C.

International journal of cancer, 2021-05, Vol.148 (9), p.2335-2344 [Periódico revisado por pares]

Hoboken, USA: John Wiley & Sons, Inc

Texto completo disponível